{
    "Trade/Device Name(s)": [
        "Xpert MRSA"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K070462",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033415"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX"
    ],
    "Summary Letter Date": "April 17, 2007",
    "Summary Letter Received Date": "February 16, 2007",
    "Submission Date": "February 16, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA) DNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GeneXpert Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid amplification",
        "Automated sample preparation",
        "Multiplex PCR"
    ],
    "Methodologies": [
        "PCR-based detection",
        "DNA amplification",
        "Molecular diagnostics"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Automated system",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert MRSA real-time PCR assay for rapid detection of MRSA DNA from nasal swabs using the GeneXpert Dx System.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) from nasal swabs in patients at risk for nasal colonization, to aid in the prevention and control of MRSA infections in healthcare settings.",
    "fda_folder": "Microbiology"
}